124 related articles for article (PubMed ID: 2505151)
21. Role of major histocompatibility complex class I alpha 1/alpha 2 domain polymorphism and in vivo expression pattern in tumor resistance: studies with transgenic mice and lymphoma cell transfectants.
Höglund P; Waldenström M; Kärre K
J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):175-81. PubMed ID: 8297899
[TBL] [Abstract][Full Text] [Related]
22. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein.
Ulbrecht M; Honka T; Person S; Johnson JP; Weiss EH
J Immunol; 1992 Nov; 149(9):2945-53. PubMed ID: 1401923
[TBL] [Abstract][Full Text] [Related]
23. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
24. [A novel experimental approach to immunotherapy against malignant brain tumor with the mouse IFN-gamma gene transfer].
Nishihara K
Nihon Geka Hokan; 1989 Jan; 58(1):18-42. PubMed ID: 2508589
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.
Wong GH; Clark-Lewis I; McKimm-Breschkin L; Harris AW; Schrader JW
J Immunol; 1983 Aug; 131(2):788-93. PubMed ID: 6408189
[TBL] [Abstract][Full Text] [Related]
26. Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.
Burnham DK; Mak CK; Webster RJ; Daynes RA
Transplantation; 1989 Mar; 47(3):533-42. PubMed ID: 2493701
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of regulation of MHC and anti-viral genes.
Rodgers JR; Wyde PR; Rich RR
J Immunol; 1991 Mar; 146(6):1979-86. PubMed ID: 1848575
[TBL] [Abstract][Full Text] [Related]
28. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
29. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma.
Cockfield SM; Ramassar V; Urmson J; Halloran PF
J Immunol; 1989 Feb; 142(4):1120-8. PubMed ID: 2521659
[TBL] [Abstract][Full Text] [Related]
30. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
31. Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells.
Tomkins PT; Ward GA; Morris AG
Immunology; 1988 Mar; 63(3):355-62. PubMed ID: 2832313
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin.
Carbone E; Stuber G; Andrée S; Franksson L; Klein E; Beretta A; Siccardi AG; Kärre K
Eur J Immunol; 1993 Aug; 23(8):1752-6. PubMed ID: 7688306
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells.
Bahler DW; Cerosaletti KM; Lord EM; Frelinger JG
J Immunol; 1988 Jun; 140(11):4003-12. PubMed ID: 2453562
[TBL] [Abstract][Full Text] [Related]
34. Defective assembly of class I major histocompatibility complex molecules in an embryonic cell line.
Bikoff EK; Otten GR; Robertson EJ
Eur J Immunol; 1991 Sep; 21(9):1997-2004. PubMed ID: 1716207
[TBL] [Abstract][Full Text] [Related]
35. MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.
Jones RA; Scott CS; Katz FE; Child JA
Clin Exp Immunol; 1988 Dec; 74(3):454-8. PubMed ID: 2466592
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis.
Ljunggren HG; Pääbo S; Cochet M; Kling G; Kourilsky P; Kärre K
J Immunol; 1989 Apr; 142(8):2911-7. PubMed ID: 2467945
[TBL] [Abstract][Full Text] [Related]
37. Molecular mediators and events associated with attenuated MHC class I gene expression.
Zeff RA
Semin Cancer Biol; 1991 Oct; 2(5):287-93. PubMed ID: 1773045
[TBL] [Abstract][Full Text] [Related]
38. Influence on metastasis of the reduction of major histocompatibility complex (MHC) class I gene with an antisense oligonucleotide.
Kanbe M; Arita D; Satoh T; Yokoyama A; Murakawa Y; Kikuchi H; Kanamaru R
Anticancer Drug Des; 1992 Aug; 7(4):341-50. PubMed ID: 1510801
[TBL] [Abstract][Full Text] [Related]
39. Possible mechanisms for the elevation of serum beta 2-microglobulin levels in adult T-cell leukemia.
Tsuda H; Sawada T; Sakata KM; Takatsuki K
Int J Hematol; 1992 Apr; 55(2):179-87. PubMed ID: 1511167
[TBL] [Abstract][Full Text] [Related]
40. Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression.
Yamasaki T; Akiyama Y; Fukuda M; Kimura Y; Moritake K; Kikuchi H; Ljunggren HG; Kärre K; Klein G
Int J Cancer; 1996 Jul; 67(3):365-71. PubMed ID: 8707410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
